Williams-Sonoma insider files to sell 3,500 shares on NYSE
Rhea-AI Filing Summary
Williams-Sonoma (WSM) Form 144 notice: An insider filed to sell 3,500 shares of common stock through Morgan Stanley Smith Barney on the NYSE with an approximate sale date of 09/24/2025. The filing reports an aggregate market value of $695,765.35 and states the company has 121,790,333 shares outstanding. The shares were granted as restricted stock in 2023 in three lots: 1,738 shares on 03/21/2023, 1,242 shares on 04/15/2023 and 520 shares on 04/16/2023. The filer reports no related sales in the past three months and includes the standard representation about lack of undisclosed material information.
Positive
- Full acquisition details provided including dates and grant sizes for each restricted stock lot
- No sales in the past three months reported for the filer, lowering immediate pattern-of-sales concerns
- Planned sale size is immaterial relative to outstanding shares (3,500 vs 121,790,333)
Negative
- None.
Insights
TL;DR: Small insider sale notice: 3,500 shares planned, representing a de minimis portion of outstanding equity.
The filing notifies the market of a proposed sale by a person who received restricted stock in 2023. At 3,500 shares versus 121,790,333 shares outstanding, the transaction size is immaterial to capital structure and likely has limited market impact. The use of a major broker and a definite approximate sale date indicates a routine planned disposition rather than a block trade. No recent sales were reported for the filer in the prior three months, which reduces concerns about an ongoing sell program. The filing provides acquisition dates and quantities but contains no price or proceeds details beyond the aggregate market value estimate reported for the notice.
TL;DR: Compliance-focused disclosure: Form 144 documents a planned sale of restricted shares, following required procedures.
This Form 144 supplies the information required under Rule 144: class, broker, share count, market value, acquisition method and dates. The disclosure of restricted stock origins (grants from the issuer) and specific grant dates is appropriate for assessing whether resale conditions may be satisfied. The filing contains the standard attestation regarding material non-public information. There are no indications in the form of accelerated sales, pledges, or aggregated sales obligations that would raise governance flags.